Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDs

Clinical trial NCT02066454 · COMPLETED

Trial details

NCT number: NCT02066454
Sponsor: University Hospital, Grenoble
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Myeloma Venous Thromboembolism

Start date: 2014-06-05
Primary completion: 2016-07-12
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.